Enliven Therapeutics Inc（ELVN）价格预测

$41.520

-0.407 (-0.98%)收盘时

价格预测

1-Day Price Prediction

-1.21%

1-Week Prediction

-2.27%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中打开以解锁更长周期的预测。

Loading chart…

ELVN 相似图表分析预测

Alphio's ELVN stock price prediction model matches the current Enliven Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $41.02 (-1.21%). The 1-week path is $40.58 (-2.27%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 Enliven Therapeutics Inc 股票吗？

Enliven Therapeutics Inc is a good buy right now due to its strong cash reserves of $895.2 million, which ensures liquidity until 2030, and an impressive year-to-date change of +167.18%. The current price of $41.52 is significantly below the analyst price targets, with Morgan Stanley and JPMorgan setting targets at $70 and $75, respectively, indicating potential upside of 68.7% and 80.5%. However, the main risk is the negative earnings trend, with a reported EPS of -0.49 missing estimates by 28.95%.

ELVN 股价于 Friday 收于 $41.52，此前下跌 -0.98%

Enliven Therapeutics Inc (ELVN) last closed at $41.52, losing -0.98%. These facts feed the 1-day and 1-week ELVN price prediction above.

预测驱动因素

Enliven Therapeutics Inc（ELVN）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似图表形态

近期走势与 ELVN 最接近的股票，按相似度排序。

PSN

92.65%

+62.00%

DKS

92.53%

+6.04%

PEP

92.11%

-2.62%

GGAL

91.78%

+14.12%

ONON

91.75%

+8.51%

ELVN 季节性分析

Historically the probability of a positive October return for ELVN is 65.08%. April offers the highest probability of a positive month at 67.19%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…